001445549 000__ 03621cam\a2200493Ii\4500
001445549 001__ 1445549
001445549 003__ OCoLC
001445549 005__ 20230310003837.0
001445549 006__ m\\\\\o\\d\\\\\\\\
001445549 007__ cr\un\nnnunnun
001445549 008__ 220330s2022\\\\sz\a\\\\o\\\\\001\0\eng\d
001445549 020__ $$a9783030943837$$q(electronic bk.)
001445549 020__ $$a3030943836$$q(electronic bk.)
001445549 020__ $$z9783030943820
001445549 020__ $$z3030943828
001445549 0247_ $$a10.1007/978-3-030-94383-7$$2doi
001445549 035__ $$aSP(OCoLC)1306275292
001445549 040__ $$aYDX$$beng$$erda$$epn$$cYDX$$dGW5XE$$dOCLCO$$dEBLCP$$dCASUM$$dUKAHL$$dOCLCQ
001445549 049__ $$aISEA
001445549 050_4 $$aRC523$$b.P53 2022
001445549 08204 $$a616.8/311061$$223
001445549 24500 $$aPharmacological treatment of Alzheimer's disease :$$bscientific and clinical aspects /$$cGustavo Alves Andrade dos Santos, editor.
001445549 264_1 $$aCham :$$bSpringer,$$c[2022]
001445549 264_4 $$c©2022
001445549 300__ $$a1 online resource :$$billustrations (some color)
001445549 336__ $$atext$$btxt$$2rdacontent
001445549 337__ $$acomputer$$bc$$2rdamedia
001445549 338__ $$aonline resource$$bcr$$2rdacarrier
001445549 500__ $$aIncludes index.
001445549 5050_ $$a1. Introduction -- 2. Principles of Pharmacology in Dementia -- 3. The Viability of Treatment Conditioned to the Pathophysiology of Alzheimer's Disease -- 4. The Use of Esterase Inhibitors -- 5. Pharmacology of NMDA (N-methyl-D-aspartate) receptor antagonists in Alzheimers Disease -- 6. Supportive Pharmacological Treatment -- 7. Herbal Medicines and Supplements -- 8. Emergency Situations -- 9. Relationships between Treatment and Clinical Evaluations -- 10. New Perspectives for Treatment in Alzheimer's Disease.
001445549 506__ $$aAccess limited to authorized users.
001445549 520__ $$aAlzheimers disease is the most prevalent form of dementia. Although it was discovered about a century ago, the first drugs applied in treatment were only introduced in therapy in the last 30 years. This book focuses on the clinical pharmacology of drugs that aim to delay the progression of Alzheimers disease, such as anticholinesterases and glutamate receptor antagonists, as well as treatment for the behavioral changes caused by the progression of the disease: antidepressants, antipsychotics, anxiolytics, and mood stabilizers. In addition, it describes important information about the pathophysiology and diagnostic methods of Alzheimers disease, emergency situations conditioned by the dementia process, and presents new perspectives for the treatment of Alzheimers disease. The ten chapters cover topics such as mechanism of action, dosage regimen, adverse reactions, drug interactions, toxicity profiles, among other information of clinical relevance. The work comprises evidence-based studies, providing a valuable resource for analyzing, prescribing and monitoring patients being treated for Alzheimers disease. Written by experts with solid professional experience, this book will appeal to pharmacologists, geriatricians, neurologists, psychiatrists, biomedical clinicians, and other healthcare professionals.
001445549 588__ $$aDescription based on print version record.
001445549 650_0 $$aAlzheimer's disease$$xChemotherapy.
001445549 650_6 $$aMaladie d'Alzheimer$$xChimiothérapie.
001445549 655_0 $$aElectronic books.
001445549 7001_ $$aSantos, Gustavo Alves Andrade dos,$$eeditor.
001445549 77608 $$iPrint version:$$tPharmacological treatment of Alzheimer's disease.$$dCham : Springer, 2022$$z9783030943820$$w(OCoLC)1295191174
001445549 852__ $$bebk
001445549 85640 $$3Springer Nature$$uhttps://univsouthin.idm.oclc.org/login?url=https://link.springer.com/10.1007/978-3-030-94383-7$$zOnline Access$$91397441.1
001445549 909CO $$ooai:library.usi.edu:1445549$$pGLOBAL_SET
001445549 980__ $$aBIB
001445549 980__ $$aEBOOK
001445549 982__ $$aEbook
001445549 983__ $$aOnline
001445549 994__ $$a92$$bISE